Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment

Journal of Crohn's and Colitis

Volumn 6, Issue 9, 2012, Pages 881-886

  Casellas, Francesc ^a   Robles, Virginia ^a   Borruel, Natalia ^a   Torrejón, Antonio ^a   Castells, Isabel ^a   Navarro, Esther ^a   Guarner, Francisco ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Crohn's disease; Cut off value; Quality of life; Restoration of health; Ulcerative colitis

Indexed keywords

ADALIMUMAB; INFLIXIMAB;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; CONVALESCENCE; CROHN DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH BELIEF; HUMAN; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE 36; MAINTENANCE CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865803128     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.01.019     Document Type: Article

References (18)

1. Pajares J.M., Gisbert J.P. Epidemiology of inflammatory bowel disease in Spain. A systematic review. Rev Enf Dig 2001, 93:15-20.
2. Peyrin-Biroulet L., Loftus E.V., Colombel J.F., Sandborn W.J. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010, 105:289-297.
3. Vergara M., Montserrat A., Casellas F., Villoria A., Suarez D., Maudsley M., et al. Calvet XA New Validation of the Spanish Work Productivity and Activity Impairment Questionnaire-Crohn's Disease Version. Inflamm Bowel Dis 2011, 17:2350-2357.
4. Casellas F., Panés J., García-Sánchez V., Ginard D., Gomollón F., Hinojosa J., et al. Costes médicos directos de la enfermedad de Crohn en España. Pharmacoeconomics 2010, 7:38-46. [Spanish Research Articles].
5. Iglesias M., Barreiro de Acosta M., Vázquez I., Figueiras A., Nieto L., Lorenzo A., et al. Psychological impact of Crohn's disease on patients in remission: anxiety and depression risks. Rev Esp Enferm Dig 2009, 101:249-257.
6. Casellas F., Arenas J.I., Baudet J.S., Fabregas S., Garcia N., Gelabert J., et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005, 11:488-496.
7. Casellas F., Alcalá M.J., Prieto L., Armengol J.R., Malagelada J.R. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am J Gastroenterol 2004, 99:457-461.
8. Casellas F., López Vivancos J., Badia X., Vilaseca J., Malagelada J.R. Impact of surgery for Crohn's disease on health-related quality of life. Am J Gastroenterol 2000, 95:177-182.
9. Casellas F., Rodrigo L., Niño P., Pantiga C., Riestra S., Malagelada J.R. Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years. Inflamm Bowel Dis 2007, 13:1395-1400.
10. Iglesias M., Barreiro de Acosta M., Figueiras A., Nieto L., Piñeiro M., Gómez R., et al. Calidad de vida en pacientes con enfermedad de Crohn en remisión. Rev Esp Enferm Dig 2010, 102:624-630.
11. Lewis J.D., Chuai S., Nessel L., Lichtenstein G.R., Aberra F.N., Ellenberg J.H. Use of non-invasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 2008, 14:1660-1666.
12. Hlavaty T., Persoons P., Vermeire S., Ferrante M., Pierik M., Van Assche G., et al. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease. Inflamm Bowel Dis 2006, 12:199-204.
13. Huaman J.W., Casellas F., Borruel N., Peláez A., Torrejón A., Castells I., et al. Cutoff values of the Inflammatory Bowel Disease Questionnaire to predict a normal health related quality of life. J Crohns Colitis 2010, 4:637-641.
14. O'Morain C., Tobin A., Leen E., Suzuki Y., O'Riordan T. Criteria of case definition in Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1989, 170:7-11. Suppl.
15. Walmsley R.S., Ayres R.C., Pounder R.E., Allan R.N. A simple clinical colitis activity index. Gut 1998, 43:29-32.
16. Harvey R.F., Bradshaw J.M. A simple index of Crohn's disease activity. Lancet 1980, 1:154.
17. López-Vivancos J., Casellas F., Badia X., Vilaseca J., Malagelada J.R. Validation of the Spanish version of the Inflammatory Bowel Disease. Questionnaire on ulcerative colitis and Crohn's Disease. Digestion 1999, 60:274-280.
18. Love J.R., Irvine E.J., Fedorak R.N. Quality of life in inflammatory bowel disease. J Clin Invest 1992, 14:15-19.